Profile for Lexicon Pharmaceuticals Inc. (LXRX)

$ 1.75   -0.11 (-5.91%) Volume: 844.81k 4:00 PM EDT Apr 7, 2020
After Hours:  $ 1.79   0.04 (+2.29%) Volume: 9.43k 5:41 PM EDT Apr 7, 2020
Business Description:
Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
Address: 8800 Technology Forest Place, The Woodlands, TX, USA, 77381
Telephone: +1 281 863-3000 Website: http://www.lexpharma.com
Facsimile: +1 281 863-8088 Email: N/A
Details
CEO: Lonnel Coats
Employees: 184 Market Cap: 187.2m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1062822
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Biological Products, Except Diagnostic Substances (2836)